The page is the record's research on the issuer — no analyst, no rating, no view. # Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Atea Pharmaceuticals, Inc. is listed on NASDAQ under ticker AVIR, with ISIN US04683R1068. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-MA. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, the jurisdiction is United States, Massachusetts, and the segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 34 filings in the window from 2025-11-08 to 2026-11-08, on 17 filing days. The median gap between filing days is 18.0 days. The latest filing is dated 2026-10-06, a regulatory filing, 33 days before the record date of 2026-11-08. The exchange median is 52 filings, a 6.0-day cadence gap and 5.0 days of latency across 4359 NASDAQ issuers. The sector median is 63.0 filings, a 6.0-day cadence gap and 4.0 days of latency across 526 issuers in 2834 Pharmaceutical Preparations. The issuer's 34 filings are below both medians. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client_categories and so cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research house was found on the issuer's investor-relations page, and the count is 0. ## Open research No openly published research note was found, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001593899.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/AVIR (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/AVIR (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/AVIR · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp